health
NIH funded study shows modified HIV drug reverses vision loss and paralysis in multiple sclerosis model
A new National Institutes of Health (NIH)─funded study indicates that the experimental drug kamuvudine─9 (K─9) facilitates recovery from pre─existing vision loss and paralysis in animal models of multiple sclerosis
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories
What happens when middle-aged adults take creatine for 12 weeks? New study finds muscle gains even without structured exercise
The Economic Times

Study Links Oral Menopausal Hormone Therapy to Thrombotic Risk
Drug Topics

Smartphone retinal imaging could expand global eye care screening
News-Medical

Why does endometriosis only cause major pain for some?
Futurity

Are You Always Up Past Midnight? Study Reveals How Sleeping Late May Affect Your Body’s Cancer Defences
News18